Cytoplasmic FBXO38 mediates PD-1 degradation

被引：1

作者：

Liu, Xiwei ^{[1
]}

Meng, Xiangbo ^{[2
]}

Lin, Zuomiao ^{[3
]}

Jiang, Shutan ^{[1
]}

Liu, Haifeng ^{[1
]}

Sun, Shao-cong ^{[4
]}

Liu, Xiaolong ^{[1
]}

Zhou, Penghui ^{[5
]}

Huang, Xiaowu ^{[6
,7
,8
]}

Wei, Lai ^{[9
]}

Yang, Wei ^{[10
,11
]}

Xu, Chenqi ^{[1
,3
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai, Peoples R China

[2] Shandong Univ, Adv Med Res Inst, Cheeloo Coll Med, Meili Lake Translat Res Pk, Jinan, Shandong, Peoples R China

[3] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Hangzhou, Peoples R China

[4] Chinese Inst Med Res, Inst Immunol, Beijing, Peoples R China

[5] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China

[6] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai 200032, Peoples R China

[7] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China

[8] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai 200032, Peoples R China

[9] Guangzhou Med Univ, Affiliated Hosp 2, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510000, Peoples R China

[10] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangdong Prov Key Lab Mol Oncol Pathol, Guangzhou, Peoples R China

[11] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Peoples R China

来源：

EMBO REPORTS | 2024年 / 25卷 / 10期

关键词：

MOKA;

D O I：

10.1038/s44319-024-00254-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Comment on “FBXO38 is dispensable for PD-1 regulation” by Dibus et al,

引用

页码：4168 / 4171

页数：4

共 50 条

[31] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Bai, Jie
Gao, Zhitao
Li, Xiang
Dong, Liang
Han, Weidong
Nie, Jing
ONCOTARGET, 2017, 8 (66) : 110693 - 110707
[32] PD-1 in RA
Kristjansdottir, H.
Grondal, G.
Erlendsson, K.
Steinsson, K.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 14 - 14
[33] The PD-1 Interactome
Wang, Qi
Bardhan, Kankana
Boussiotis, Vassiliki A.
Patsoukis, Nikolaos
ADVANCED BIOLOGY, 2021, 5 (09):
[34] Impeding PD-1
Scudellari, Megan
SCIENTIST, 2008, 22 (10): : 57 - 58
[35] PD-1 and Autoimmunity
Kasagi, Shimpei
Kawano, Seiji
Kumagai, Shunichi
CRITICAL REVIEWS IN IMMUNOLOGY, 2011, 31 (04) : 265 - 295
[36] PD-1 Blockers
Wolchok, Jedd D.
CELL, 2015, 162 (05) : 937 - 937
[37] PD-1 mediates decidual γδT cells cytotoxicity during recurrent pregnancy loss
Guo, Rong
Jiang, Silin
Zhang, Jianliang
Yang, Quanli
Gao, Liang
Xia, Wei
Tong, Lingxia
Feng, Peiran
Xu, Yan
Zhang, Tao
Cheng, Hao
Liu, CuiPing
Zhang, Xueguang
Yin, Zhinan
Zhang, Hong
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 88 (03)
[38] PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Beldi-Ferchiou, Asma
Lambert, Marion
Dogniaux, Stephanie
Vely, Frederic
Vivier, Eric
Olive, Daniel
Dupuy, Stephanie
Levasseur, Frank
Zucman, David
Lebbe, Celeste
Sene, Damien
Hivroz, Claire
Caillat-Zucman, Sophie
ONCOTARGET, 2016, 7 (45) : 72961 - 72977
[39] PD-1 mediates brain resident memory T cell formation and virus control
Butic, Arrienne
Lauver, Matthew
Lukacher, Aron
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
[40] CD38-Mediated Immunometabolic Suppression as a Mechanism of Resistance to PD-1/PD-L1 Axis Blockade
Chen, L.
Diao, L.
Yang, Y.
Yi, X.
Rodriguez, B. L.
Li, Y.
Rodriguez-Canales, J.
Liu, X.
Huang, A.
Zhao, Q.
Peng, D.
Fradette, J.
Tong, P.
Ungewiss, C.
Fan, Y.
Peng, D.
Villalobos, P.
Dmitrovsky, E.
Papadimitrakopoulou, V.
Wang, J.
Byers, L. A.
Heymach, J.
Ullrich, S.
Wistuba, I.
Qin, X.
Gibbons, D.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1779 - S1779

← 1 2 3 4 5 →